Diana M. Escolar

4.7k total citations
49 papers, 2.0k citations indexed

About

Diana M. Escolar is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Diana M. Escolar has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Physiology. Recurrent topics in Diana M. Escolar's work include Muscle Physiology and Disorders (25 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Lysosomal Storage Disorders Research (6 papers). Diana M. Escolar is often cited by papers focused on Muscle Physiology and Disorders (25 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Lysosomal Storage Disorders Research (6 papers). Diana M. Escolar collaborates with scholars based in United States, France and Netherlands. Diana M. Escolar's co-authors include Julaine Florence, Erik Henricson, J. Mayhew, Eric P. Hoffman, Paula R. Clemens, Robert T. Leshner, Andrea Gropman, Aaron H. Burstein, Kathryn R. Wagner and Sherifa A. Hamed and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Diana M. Escolar

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana M. Escolar United States 20 1.5k 373 326 288 241 49 2.0k
Hirofumi Komaki Japan 28 1.7k 1.2× 261 0.7× 286 0.9× 285 1.0× 363 1.5× 180 2.5k
Angela Berardinelli Italy 22 1.2k 0.8× 279 0.7× 289 0.9× 272 0.9× 333 1.4× 70 1.8k
Adnan Y. Manzur United Kingdom 26 1.5k 1.0× 195 0.5× 528 1.6× 535 1.9× 351 1.5× 63 2.1k
J. T. Kissel United States 28 1.1k 0.7× 523 1.4× 235 0.7× 353 1.2× 817 3.4× 50 2.8k
Maggie C. Walter Germany 32 1.8k 1.2× 439 1.2× 420 1.3× 718 2.5× 558 2.3× 122 2.9k
Nancy D. Leslie United States 18 929 0.6× 523 1.4× 154 0.5× 172 0.6× 93 0.4× 37 1.7k
Francesco Fortunato Italy 29 1.5k 1.0× 232 0.6× 183 0.6× 647 2.2× 389 1.6× 97 2.5k
B. Eymard France 29 1.5k 1.0× 206 0.6× 771 2.4× 272 0.9× 439 1.8× 82 2.6k
Rohit Bhattacharjee New Zealand 5 1.3k 0.9× 182 0.5× 340 1.0× 343 1.2× 519 2.2× 7 1.7k
Miriam Rodrigues Brazil 5 1.3k 0.9× 187 0.5× 348 1.1× 346 1.2× 520 2.2× 7 1.7k

Countries citing papers authored by Diana M. Escolar

Since Specialization
Citations

This map shows the geographic impact of Diana M. Escolar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana M. Escolar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana M. Escolar more than expected).

Fields of papers citing papers by Diana M. Escolar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana M. Escolar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana M. Escolar. The network helps show where Diana M. Escolar may publish in the future.

Co-authorship network of co-authors of Diana M. Escolar

This figure shows the co-authorship network connecting the top 25 collaborators of Diana M. Escolar. A scholar is included among the top collaborators of Diana M. Escolar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana M. Escolar. Diana M. Escolar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anastasiadou, Eleni, Anita G. Seto, Xuan Beatty, et al.. (2020). Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo. Clinical Cancer Research. 27(4). 1139–1149. 110 indexed citations
2.
Peay, Holly L., Barbara B. Biesecker, Benjamin S. Wilfond, et al.. (2018). Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders. Clinical Trials. 15(2). 139–148. 30 indexed citations
3.
Bush, E.W., Christopher W. Ward, Thomas M. Suchyna, et al.. (2017). AT-300, a calcium modulator, improves muscle force production and decreases muscle degeneration in D2-mdx model of Duchenne muscular dystrophy. Neuromuscular Disorders. 27. S192–S192. 1 indexed citations
4.
Zaidman, Craig M., Lucy Lu Wang, Anne M. Connolly, et al.. (2015). Electrical impedance myography in duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity. Muscle & Nerve. 52(4). 592–597. 44 indexed citations
5.
6.
7.
Sparks, Susan & Diana M. Escolar. (2011). Congenital muscular dystrophies. Handbook of clinical neurology. 101. 47–79. 14 indexed citations
8.
Scharner, Juergen, Charlotte A. Brown, Matthew Bower, et al.. (2010). Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations. Human Mutation. 32(2). 152–167. 55 indexed citations
9.
Laforêt, Pascal, Deya Corzo, Diana M. Escolar, et al.. (2008). T.O.4 Safety and efficacy results from a randomized, double-blind, placebo-controlled study of alglucosidase alfa for the treatment of Pompe disease in juveniles and adults. Neuromuscular Disorders. 18(9-10). 832–833. 5 indexed citations
10.
Wokke, John H. J., Diana M. Escolar, Alan Pestronk, et al.. (2008). Clinical features of late‐onset Pompe disease: A prospective cohort study. Muscle & Nerve. 38(4). 1236–1245. 132 indexed citations
11.
Jaffe, Kenneth M., John H. J. Wokke, Pascal Laforêt, et al.. (2007). M.P.2.05 Late onset Pompe disease is associated with impaired pulmonary and muscle function and diminished health-related quality of life. Neuromuscular Disorders. 17(9-10). 794–794. 1 indexed citations
12.
Escolar, Diana M., Carolina Tesi Rocha, Paula R. Clemens, et al.. (2007). G.P.9.09 Immediate release oral pentoxifylline is poorly tolerated in Duchenne muscular dystrophy boys. Neuromuscular Disorders. 17(9-10). 817–817. 2 indexed citations
13.
Escolar, Diana M., et al.. (2006). G.P.1 01 Clinical presentation and disease progression in late-onset Pompe disease. Neuromuscular Disorders. 16(9-10). 654–654. 1 indexed citations
14.
15.
Godfrey, Caroline, Diana M. Escolar, Martin Brockington, et al.. (2006). Fukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy. Annals of Neurology. 60(5). 603–610. 108 indexed citations
16.
Mendell, Jerry R., Cristina Csimma, Craig M. McDonald, et al.. (2006). Challenges in drug development for muscle disease: A stakeholders' meeting. Muscle & Nerve. 35(1). 8–16. 28 indexed citations
17.
Donaldson, Michael, Jeffrey L. Jensen, Martin Tristani‐Firouzi, et al.. (2003). PIP(2) binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
18.
Tranebjærg, Lisbeth, Tanya M. Teslovich, MaryPat Jones, et al.. (2003). Genome-wide homozygosity mapping localizes a gene for autosomal recessive non-progressive infantile ataxia to 20q11-q13. Human Genetics. 113(3). 293–295. 13 indexed citations
19.
Koul, Roshan, et al.. (2001). Severe autosomal recessive rippling muscle disease. Muscle & Nerve. 24(11). 1542–1547. 15 indexed citations
20.
Escolar, Diana M. & H. Royden Jones. (1996). Pediatric radial mononeuropathies: A clinical and electromyographic study of sixteen children, with review of the literature. Muscle & Nerve. 19(7). 876–883. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirofumi Komaki Breakdown of academic impact, for papers by Angela Berardinelli Breakdown of academic impact, for papers by Adnan Y. Manzur Breakdown of academic impact, for papers by J. T. Kissel Breakdown of academic impact, for papers by Maggie C. Walter Breakdown of academic impact, for papers by Nancy D. Leslie Breakdown of academic impact, for papers by Francesco Fortunato Breakdown of academic impact, for papers by B. Eymard Breakdown of academic impact, for papers by Rohit Bhattacharjee Breakdown of academic impact, for papers by Miriam Rodrigues
Rankless by CCL
2026